OOIR: Observatory of International Research

Papers

(The TQCC of Therapeutic Advances in Psychopharmacology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?	40
What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications	33
Clinical pharmacist interventions in elderly patients with mental disorders in primary care focused on psychotropics: a retrospective pre–post observational study	23
Clozapine discontinuation withdrawal symptoms in schizophrenia	21
Repetitive transcranial magnetic stimulation for major depressive disorder: basic principles and future directions	21
Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies	20
Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders	20
Transcranial magnetic stimulation for post-traumatic stress disorder	19
The role of lumateperone in the treatment of schizophrenia	17
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review	17
Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review	16
Trends in benzodiazepine receptor agonists use and associated factors in the Belgian general older population: analysis of the Belgian health interview survey data	16
Cognitive effects of vortioxetine in older adults: a systematic review	15
Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review	14
Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review	13
Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants	12
Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action	12
Effectiveness of 2-year treatment with aripiprazole long-acting injectable and comparison with paliperidone palmitate	12
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study	12
Asenapine: an atypical antipsychotic with atypical formulations	12
Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review	12
Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine	11
Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey	11
Liquorice for pain?	10
History repeating: guidelines to address common problems in psychedelic science	10

Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update	10
Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA	9
Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication	8
Pathophysiology, prognosis and treatment of tardive dyskinesia	8
Classic psychedelics, health behavior, and physical health	8
Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry	8
Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies	7
Exercise interventions to reduce anxiety in mid-life and late-life anxiety disorders and subthreshold anxiety disorder: a systematic review	7
Synthetic opioids: a review and clinical update	7
The effect of monoamine oxidase-B inhibitors on the alleviation of depressive symptoms in Parkinson’s disease: meta-analysis of randomized controlled trials	7
Will psilocybin lose its magic in the clinical setting?	7
Treatment strategies for clozapine-induced hypotension: a systematic review	7
Efficacy and safety of cariprazine augmentation in patients treated with clozapine: a pilot study	7
Identification of clinical phenotypes in schizophrenia: the role of lurasidone	7
Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital	7
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series	7